As a potent vasoconstrictor, it is unsurprising that ET-1 has been implicated in many cardiovascular diseases (CVDs) and is commonly associated with endothelial dysfunction, which underlies disease. This evidence concerns the gene EDN1 and endothelial dysfunction.